Hodgkin's disease and CD30-positive anaplastic large cell lymphomas--a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study
- PMID: 2173409
- PMCID: PMC1877680
Hodgkin's disease and CD30-positive anaplastic large cell lymphomas--a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study
Abstract
The authors have examined cellular areas of lymphoma tissue in 28 cases of Hodgkin's disease (HD) or anaplastic large cell lymphoma (ALCL, 'Ki-1 cell lymphoma') to evaluate the boundaries between the two entities. Methods applied included conventional histology; test point analysis; semiautomated morphometry of nuclear profile features of Reed-Sternberg and other atypical large cells (RSALCs); and immunohistochemistry of these elements on all paraffin sections and, in 15 cases, on frozen sections. Mean nuclear profile morphotypes of RSALCs per case varied independently of immunophenotype and histologic diagnosis. Conversely, immunohistochemistry demonstrated significant, although not consistent, preferential positivities of these CD30+ elements for CD15 in HD, and for epithelial membrane antigen (EMA) and CD43 in ALCLs. In the latter, RSALCs also exhibited a tendency for CD45 and CD45RO positivity and for the expression of T-cell-associated antigens. However, there were considerable overlaps. This continuous spectrum of RSALC nuclear profile morphotypes and immunophenotypes, ranging from HD over questionable cases, intermediate between HD and ALCL, to ALCLs, was paralleled by differences in the reactive component of lymphomas. Lymphocytes and granulocytes were significantly deficient in ALCLs.
Similar articles
-
CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.Arch Pathol Lab Med. 1992 Nov;116(11):1197-201. Arch Pathol Lab Med. 1992. PMID: 1332642
-
CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis.Int J Oncol. 2003 Feb;22(2):319-24. Int J Oncol. 2003. PMID: 12527929
-
Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.Anticancer Res. 1999 Sep-Oct;19(5B):3933-8. Anticancer Res. 1999. PMID: 10628334
-
The interface of Hodgkin's disease and anaplastic large cell lymphoma.Cancer Surv. 1997;30:87-105. Cancer Surv. 1997. PMID: 9547988 Review.
-
Anaplastic large-cell Ki-1 malignant lymphomas. Recognition, biological and clinical implications.Pathol Annu. 1991;26 Pt 1:1-24. Pathol Annu. 1991. PMID: 1849627 Review.
Cited by
-
MUC1 (EMA) is preferentially expressed by ALK positive anaplastic large cell lymphoma, in the normally glycosylated or only partly hypoglycosylated form.J Clin Pathol. 2001 Dec;54(12):933-9. doi: 10.1136/jcp.54.12.933. J Clin Pathol. 2001. PMID: 11729213 Free PMC article.
-
Advances in immunotherapeutic targets for childhood cancers: A focus on glypican-2 and B7-H3.Pharmacol Ther. 2021 Jul;223:107892. doi: 10.1016/j.pharmthera.2021.107892. Epub 2021 May 14. Pharmacol Ther. 2021. PMID: 33992682 Free PMC article. Review.
-
The Pathological Spectrum of Systemic Anaplastic Large Cell Lymphoma (ALCL).Cancers (Basel). 2018 Apr 4;10(4):107. doi: 10.3390/cancers10040107. Cancers (Basel). 2018. PMID: 29617304 Free PMC article. Review.
-
Paraffin section immunohistochemistry in the diagnosis of Hodgkin's disease and anaplastic large cell (CD30+) lymphomas.Virchows Arch A Pathol Anat Histopathol. 1992;420(6):527-32. doi: 10.1007/BF01600258. Virchows Arch A Pathol Anat Histopathol. 1992. PMID: 1376944
-
Immunoreactivity of CD99 in non-Hodgkin's lymphoma: unexpected frequent expression in ALK-positive anaplastic large cell lymphoma.J Korean Med Sci. 2005 Dec;20(6):952-6. doi: 10.3346/jkms.2005.20.6.952. J Korean Med Sci. 2005. PMID: 16361803 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous